News » November 15, 2013
Pfizer Renews its Chair with the Université de Sherbrooke
The Université de Sherbrooke and Pfizer have announced that the Pfizer Chair of Process Analytical Technologies …
Learn moreNews » November 5, 2013
Immune Biosolutions Receives $250,000 from Economic Development Canada
Immune Biosolutions, a Sherbrooke-based company, received $250,000 in financial assistance from Economic …
Learn moreNews » October 26, 2013
Laboratoire M2 Receives $400,000 in Financial Assistance
Laboratoire M2 received $400,000 in financial assistance from the Québec government in support of the …
Learn moreNews » October 26, 2013
Immune Biosolutions and Lumed Are Finalists in the 3rd Devtech 50 competition
Immune Biosolutions and Lumed, both Sherbrooke-based companies, are 2 of the 11 finalists in the 3rd …
Learn moreNews » October 12, 2013
Merck gives a $4 million research grant to the UdeS Faculty of Medicine and Health Sciences
The Faculty of Medicine and Health Sciences (FMSS) of the Université de Sherbrooke received a major grant …
Learn moreNews » October 8, 2013
$135 Million in New Capital for Canadian Health-Care Companies
There is some good news for Canadian health-care companies: BDC Venture Capital has injected $135 million …
Learn moreNews » September 30, 2013
NEOMED and Three Sherbrooke Researchers Take On the Flu Virus
NEOMED is starting its first drug development project with three researchers from the Institut de pharmacologie …
Learn moreNews » September 29, 2013
Immune Biosolutions: Spin Master Innovation Fund Recipient
Immune Biosolutions continues to shine: the Sherbrooke-based company is one of five recipients of the …
Learn moreNews » August 5, 2013
Five Years of Success for Anges Québec
Anges Québec, a private-investor network, is celebrating its fifth anniversary in 2013. The organization …
Learn more
